Adjusting for medication status in genome-wide association studies
View ORCID ProfileAmanda H.W. Chong, View ORCID ProfileChristopher Kintu, Yoonsu Cho, View ORCID ProfileSegun Fatumo, Jason Torres, View ORCID ProfileGeorge Davey Smith, View ORCID ProfileTom R. Gaunt, View ORCID ProfileGibran Hemani
doi: https://doi.org/10.1101/2024.02.19.24303028
Amanda H.W. Chong
1MRC Integrative Epidemiology Unit, Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, United Kingdom
Christopher Kintu
2MRC/UVRI and LSHTM Uganda Research Unit, Entebbe, Uganda
Yoonsu Cho
1MRC Integrative Epidemiology Unit, Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, United Kingdom
Segun Fatumo
2MRC/UVRI and LSHTM Uganda Research Unit, Entebbe, Uganda
3Department of Non-Communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, UK
Jason Torres
4Medical Research Council Population Health Research Unit, Clinical Trial Service Unit and Epidemiological Studies Unit, Nuffield Department of Population Health, University of Oxford, Oxford, UK
George Davey Smith
1MRC Integrative Epidemiology Unit, Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, United Kingdom
4Medical Research Council Population Health Research Unit, Clinical Trial Service Unit and Epidemiological Studies Unit, Nuffield Department of Population Health, University of Oxford, Oxford, UK
Tom R. Gaunt
1MRC Integrative Epidemiology Unit, Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, United Kingdom
5NIHR Bristol Biomedical Research Centre, University Hospitals Bristol and Weston NHS Foundation Trust and University of Bristol
Gibran Hemani
1MRC Integrative Epidemiology Unit, Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, United Kingdom
5NIHR Bristol Biomedical Research Centre, University Hospitals Bristol and Weston NHS Foundation Trust and University of Bristol
Article usage
Posted February 20, 2024.
Adjusting for medication status in genome-wide association studies
Amanda H.W. Chong, Christopher Kintu, Yoonsu Cho, Segun Fatumo, Jason Torres, George Davey Smith, Tom R. Gaunt, Gibran Hemani
medRxiv 2024.02.19.24303028; doi: https://doi.org/10.1101/2024.02.19.24303028
Subject Area
Subject Areas
- Addiction Medicine (322)
- Allergy and Immunology (627)
- Anesthesia (163)
- Cardiovascular Medicine (2362)
- Dermatology (206)
- Emergency Medicine (378)
- Epidemiology (11750)
- Forensic Medicine (10)
- Gastroenterology (701)
- Genetic and Genomic Medicine (3717)
- Geriatric Medicine (348)
- Health Economics (632)
- Health Informatics (2386)
- Health Policy (929)
- Hematology (340)
- HIV/AIDS (779)
- Medical Education (364)
- Medical Ethics (104)
- Nephrology (398)
- Neurology (3480)
- Nursing (197)
- Nutrition (522)
- Oncology (1816)
- Ophthalmology (535)
- Orthopedics (218)
- Otolaryngology (286)
- Pain Medicine (232)
- Palliative Medicine (66)
- Pathology (445)
- Pediatrics (1029)
- Primary Care Research (418)
- Public and Global Health (6127)
- Radiology and Imaging (1270)
- Respiratory Medicine (825)
- Rheumatology (379)
- Sports Medicine (321)
- Surgery (400)
- Toxicology (50)
- Transplantation (171)
- Urology (145)